High-rolling investors have positioned themselves bullish on Edwards Lifesciences EW, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in EW often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 8 options trades for Edwards Lifesciences. This is not a typical pattern.
The sentiment among these major traders is split, with 100% bullish and 0% bearish. Among all the options we identified, there was one put, amounting to $45,570, and 7 calls, totaling $503,070.
Expected Price Movements
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $77.5 for Edwards Lifesciences over the last 3 months.
Analyzing Volume & Open Interest
In today's trading context, the average open interest for options of Edwards Lifesciences stands at 54.0, with a total volume reaching 16,185.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Edwards Lifesciences, situated within the strike price corridor from $75.0 to $77.5, throughout the last 30 days.
Edwards Lifesciences 30-Day Option Volume & Interest Snapshot
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EW | CALL | SWEEP | BULLISH | 03/21/25 | $1.4 | $1.35 | $1.35 | $75.00 | $151.3K | 42 | 1.4K |
| EW | CALL | SWEEP | BULLISH | 03/21/25 | $1.7 | $1.55 | $1.65 | $75.00 | $97.2K | 42 | 3.1K |
| EW | CALL | SWEEP | BULLISH | 03/21/25 | $1.6 | $1.55 | $1.6 | $75.00 | $81.2K | 42 | 1.8K |
| EW | CALL | SWEEP | BULLISH | 03/21/25 | $1.65 | $1.55 | $1.65 | $75.00 | $62.5K | 42 | 4.1K |
| EW | CALL | SWEEP | BULLISH | 03/21/25 | $1.6 | $1.55 | $1.6 | $75.00 | $53.1K | 42 | 3.5K |
About Edwards Lifesciences
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
In light of the recent options history for Edwards Lifesciences, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Current Position of Edwards Lifesciences
- Currently trading with a volume of 2,056,732, the EW's price is up by 0.45%, now at $69.24.
- RSI readings suggest the stock is currently may be oversold.
- Anticipated earnings release is in 11 days.
Professional Analyst Ratings for Edwards Lifesciences
1 market experts have recently issued ratings for this stock, with a consensus target price of $60.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * An analyst from Wolfe Research downgraded its action to Underperform with a price target of $60.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Edwards Lifesciences options trades with real-time alerts from Benzinga Pro.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
